Association of genetic variation of the adiponectin gene with body fat distribution and carotid atherosclerosis in Japanese obese subjects

Journal of Atherosclerosis and Thrombosis

Volumn 14, Issue 1, 2007, Pages 19-26

  Katsuda, Yuko ^a   Asano, Akimichi ^a   Murase, Yuko ^a   Chujo, Daisuke ^a   Yagi, Kunimasa ^a   Kobayashi, Junji ^a   Mabuchi, Hiroshi ^a   Yamagishi, Masakazu ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

PCR RFLP; Plaque score; Polymorphism; Visceral obesity

Indexed keywords

ADIPONECTIN;

AGED; ALLELE; ARTICLE; BODY FAT DISTRIBUTION; CAROTID ARTERY DISEASE; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENETICS; GENOTYPE; HUMAN; JAPAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY;

ADIPONECTIN; AGED; ALLELES; BODY FAT DISTRIBUTION; CAROTID ARTERY DISEASES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; JAPAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; TOMOGRAPHY, X-RAY COMPUTED; VARIATION (GENETICS);

EID: 34249859116     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.14.19     Document Type: Article

References (35)

1. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, and Matsubara K: cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (Ad-iPose Most abundant Gene transcript 1). Biochem Biophys Res Commun, 1996; 221:286-289
2. Scherer PE, Williams S, Fogliano M, Baldini G, and Lodish HF: A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem, 1995; 270:26746-26749
3. Combs TP Berg AH, Obici S, Scherer PE, and Rossetti L: Endogenous glucose production is inhibited by the adipose-derived protein Acrp,30. J Clin Invest, 2001; 108:1875-1881
4. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, and Kadowaki T: Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med, 2002; 8:1288-1295
5. Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, Furuyama N, Kondo H, Takahashi M, Arita Y, Komuro R, Ouchi N, Kihara S, Tochino Y. Okutomi K, Horie M, Takeda S, Aoyama T, Funahashi T, and Matsuzawa Y: Diet-induced insulin resistance in mice lacking adiponectin/ ACRP30. Nat Med, 2002; 8:731-737
6. Ouchi N, Kihara S, Arita Y, Nishida M, Matsuyama A, Okamoto Y, Ishigami M, Kuriyama H, Ishida K, Nishizawa H, Hotta K, Muraguchi M, Ohmoto Y, Yamashita S, Funahashi T. and Matsuzawa Y: Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavȩnger receptor expression in human monocyte-derived macrophages. Circulation, 2001; 103:1057-1063
7. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, Hotta K, Nishida M, Takahashi M, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Funahashi T, and Matsuzawa Y: Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-κB signaling through a cAMP-dependent pathway. Circulation, 2000; 102:1296-1301
8. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M, Nakamura T Yamashita S, Funahashi T, and Matsuzawa Y: Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation, 1999; 100:2473-2476
9. Fumeron F, Aubert R, Siddiq A, Betoulle D, Pean F, Hadjadj S, Tichet J, Wilpart E, Chesnier MC, Balkau B, Froguel P, and Marre M: Adiponectin gene polymorphisms and adiponectin levels are independently associated with the development of hyperglycemia during a 3-year period: the epidemiologic data on the insulin resistance syndrome prospective study. Diabetes, 2004; 53:1150-1157
10. Menzaghi C, Ercolino T, Di Paola R, Berg AH, Warram JH, Scherer PE, Trischitta. V, and Doria A: A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes, 2002; 51:2306-2312
11. Hara. K, Bautin P, Mori Y, Tobe K, Dina C, Yasuda K, Yamauchi T, Otabe S, Okada T, Eto K, Kadowaki H, Hagura. R, Akanuma Y. Yazaki Y, Nagai R, Taniyama M, Matsubara K, Yoda M, Nakano Y, Tomita M, Kimura S, Ito C, Froguel P, and Kadowaki T: Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes, 2002; 51:536-540
12. Lacquemant C, Froguel P, Lobbens S, Izzo P, Dina C, and Ruiz J: The adiponectin gene SNP + 45 is associated with coronary artery disease in Type 2 (non-insulin-dependent) diabetes mellitus. Diabetic Medicine, 2004; 21:776-781
13. The Examination Committee of Criteria for 'Obesity Disease' in Japan, Japan Society for the Study of Obesity: New criteria for 'obesity disease' in Japan. Circ J, 2002; 66:987-992
14. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 1997; 20:1183-1197
15. Matthews DR, Hosker JP, Rudenski AS, and Naylor BA: Homeostasis model assesment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 1985; 28:412-419
16. Yoshizumi T, Nakamura T, Yamane M, Islam AHMW, Menju M, and Yamasaki K: Abdominal fit: Standardized technique for measurement at CT. Radiology, 1999; 211:283-286
17. Nagai Y, Kitagawa K, Yamagami H, Kondo K, Hougaku H, Hori M, and Matsumoto M: Carotid artery intima-media thickness and plaque score for the risk assessment of stroke subtypes. Ultrasound Med Biol, 2002; 28:1239-1243
18. Stumvoll M, Tschritter O, Fritsche A, Staiger H, Renn W, Weisser M, Machicao F, and Haring H: Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes. Diabetes, 2002; 51:37-41
19. Kondo H, Shimomura. I, Matsukawa Y, Kumada M, Takahashi M, Matsuda M, Ouchi N, Kihara S, Kawamoto T, Sumitsuji S, Funahashi T, and Matsuzawa Y: Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome. Diabetes, 2002; 51:2325-2328
20. Ukkola O, Ravussin E, Jacobson P, and Bouchard C: Mutations in the adiponectin gene in lean and obese subjects from the Swedish obese subjects cohort. Metabolism, 2003; 52:881-884
21. Bouatia-Naji N, Meyre D, Lobbens S, Seron K, Fumeron F, Balkan B, Heude B, Jouret B, Scherer P, Dina C, Weill J, and Froguel P: ACDC/Adiponectin polymorphism are associated with severe childhood and adult obesity. Diabetes, 2006; 55:545-549
22. Murase Y, Asano A, Kobayashi J, Yamaaki N, and Mabuchi H: Impact of adiposity on carotid atherosclerosis in Japanese males with metabolic syndrome. J Intern Med, 2005; 257:311-312
23. Butte NF, Hopkinson JM, Wong WW, Smith EO, and Ellis KJ: Body composition during the first 2 years of life: an updated reference. Pediatr Res, 2000; 47:578-585
24. Taylor RW, Jones IE, Williams SM, and Goulding A: Body fat percentages measured by dual-energy X-ray absorptiometry corresponding to recently recommended body mass index cutoffs for overweight and obesity in child and adolescents aged 3-18 y. Am J Clin Nutr, 2002; 76:1416-1421
25. Marin P and Bjorntorp: Endocrine-metabolic patterns and adipose tissue distribution. Horm Res, 1993; 39:81-85
26. Rosenbaum M and Leibel RL: Role of gonadal steroids in the sexual dimorphisms in body composition and circulating concentrations of leptin. J Clin Endocrinol Metab, 1999; 84:1784-1789
27. Cooke PS and Naaz A: Role of estrogens in adipocyte development and function. Exp Biol Med, 2004; 229:1127-1135
28. Clegg D, Brown L, Woods S, and Benoit S; Gonadal hormones determine sensitivity to centrul leptin and insulin. Diabetes, 2006; 55:978-987
29. Simoncini T, Maffei S, and Basta G: Estrogens and glucocorticoids inhibit endotherial vascular cell adhesion molecule-1 expression by different transcriptional mechanisms. Circ Res, 2000; 87:19-25
30. Hsu SM, Chen YC, and Jiang MC: 17β-estradiol inhibits tumor necrosis factor-α-induced nuclear factor-κB activation by increasing nuclear factor-κB p 105 level in MCF-7 breast cancer cells. Biochem Biophys Res Commun, 2000; 279:47-52
31. Takahashi M, Arita Y, Yamagata K, Matsukawa Y, Okutomi K, Horie M, Shimomura I, Hotta K, Kuriyama H, Kihara. S, Nakamura T, Yamashita S, Funahashi T and Matsuzawa Y: Genomic structure and mutations in adipose- specific gene, adiponectin. Int J Obes Relat Metab Disord, 2000; 24:861-868
32. Fu Y, Luo N, Klein R, and Garvey WL Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lip- id accumulation. journal of Lipid Research, 2005; 46:1369- 1379
33. Pajvani UB, Du X, Combs TP, Berg AH, Rajala MW, Schulthess T, Engel J, Brownlee M, and Scherer PE: Struc- ture-function studies of the adipocyte-secreted hormone Acrp30/adiponectin: implications for metabolic regulation and bioactivity. J Biol Chem, 2003; 278:9073-9085
34. Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T, Berger JP, Wagner JA, Wu M, Knopps A, Xiang AH, Utzschneider KM, Kahn SE, Olefsky JM, Buchanan TA, and Scherer PE: Complex distribution, not absolute amount of adiponectin, correlate with thiazolidinedione- mediated improvement in insulin sensitivity. J Biol Chem, 2004; 279:12152-12162
35. Lara-Castro C, Luo N, Wallace P, Klein I, and Garvey W: Adiponectin multimeric complexes and themetabolic syndrome trait duster. Diabetes, 2006; 55:249-259